Early prediction of increased arterial stiffness in patients with chronic inflammation: a 15-year followup study of 108 patients with rheumatoid arthritis. 2011

Sella A Provan, and Kristin Angel, and Anne Grete Semb, and Petter Mowinckel, and Stefan Agewall, and Dan Atar, and Tore K Kvien
Department of Rheumatology, Diakonhjemmet Hospital, Oslo, Norway. sella.provan@diakonsyk.no

OBJECTIVE Patients with rheumatoid arthritis (RA), a chronic inflammatory disease, have increased cardiovascular morbidity and mortality. We investigated whether early markers of RA inflammatory disease activity could predict later increased levels of pulse-wave velocity (PWV) and augmentation index (AIx), 2 measures of arterial stiffness. METHODS In total 238 patients with early RA were followed longitudinally and 108 were available for the 15-year followup examination. Comprehensive baseline clinical and radiographic data were collected in 1992. Arterial stiffness, measured as AIx and PWV (Sphygmocor apparatus), was recorded at the 15-year followup. Adjusted logistic univariate and multivariate analyses were performed with levels of AIx and PWV as the dependent variables, and variables reflecting baseline RA disease activity as possible predictors. The validity of the final models was examined in linear regression analyses. RESULTS Baseline C-reactive protein (CRP) above the median predicted increased AIx (OR 3.52, 95% CI 1.04-11.90) and PWV (OR 4.84, 95% CI 1.39-16.83) at the 15-year assessment in multivariate models. Patients with elevated baseline CRP had significantly higher AIx (ß = 2.67, 95% CI 0.06-5.31, p = 0.045) and lnPWV (ß = 0.08, 95% CI 0.01-0.14, p = 0.02) after 15 years, after adjustments for age, sex, heart rate (AIx only) and mean arterial pressure. CONCLUSIONS Inflammation early in the RA disease course was associated with increased AIx and PWV after 15 years. These findings support the importance of early control of the inflammatory process in patients with RA.

UI MeSH Term Description Entries
D007249 Inflammation A pathological process characterized by injury or destruction of tissues caused by a variety of cytologic and chemical reactions. It is usually manifested by typical signs of pain, heat, redness, swelling, and loss of function. Innate Inflammatory Response,Inflammations,Inflammatory Response, Innate,Innate Inflammatory Responses
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D002097 C-Reactive Protein A plasma protein that circulates in increased amounts during inflammation and after tissue damage. C-Reactive Protein measured by more sensitive methods often for coronary heart disease risk assessment is referred to as High Sensitivity C-Reactive Protein (hs-CRP). High Sensitivity C-Reactive Protein,hs-CRP,hsCRP,C Reactive Protein,High Sensitivity C Reactive Protein
D004548 Elasticity Resistance and recovery from distortion of shape.
D005260 Female Females
D005500 Follow-Up Studies Studies in which individuals or populations are followed to assess the outcome of exposures, procedures, or effects of a characteristic, e.g., occurrence of disease. Followup Studies,Follow Up Studies,Follow-Up Study,Followup Study,Studies, Follow-Up,Studies, Followup,Study, Follow-Up,Study, Followup
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D000368 Aged A person 65 years of age or older. For a person older than 79 years, AGED, 80 AND OVER is available. Elderly
D001158 Arteries The vessels carrying blood away from the heart. Artery

Related Publications

Sella A Provan, and Kristin Angel, and Anne Grete Semb, and Petter Mowinckel, and Stefan Agewall, and Dan Atar, and Tore K Kvien
July 1994, The Journal of rheumatology,
Sella A Provan, and Kristin Angel, and Anne Grete Semb, and Petter Mowinckel, and Stefan Agewall, and Dan Atar, and Tore K Kvien
February 2017, The Journal of rheumatology,
Sella A Provan, and Kristin Angel, and Anne Grete Semb, and Petter Mowinckel, and Stefan Agewall, and Dan Atar, and Tore K Kvien
January 2009, Molecular medicine (Cambridge, Mass.),
Sella A Provan, and Kristin Angel, and Anne Grete Semb, and Petter Mowinckel, and Stefan Agewall, and Dan Atar, and Tore K Kvien
April 2008, The Journal of rheumatology,
Sella A Provan, and Kristin Angel, and Anne Grete Semb, and Petter Mowinckel, and Stefan Agewall, and Dan Atar, and Tore K Kvien
November 2009, Rheumatology (Oxford, England),
Sella A Provan, and Kristin Angel, and Anne Grete Semb, and Petter Mowinckel, and Stefan Agewall, and Dan Atar, and Tore K Kvien
November 2003, European heart journal,
Sella A Provan, and Kristin Angel, and Anne Grete Semb, and Petter Mowinckel, and Stefan Agewall, and Dan Atar, and Tore K Kvien
December 2004, Annals of the rheumatic diseases,
Sella A Provan, and Kristin Angel, and Anne Grete Semb, and Petter Mowinckel, and Stefan Agewall, and Dan Atar, and Tore K Kvien
April 2015, The Journal of rheumatology,
Sella A Provan, and Kristin Angel, and Anne Grete Semb, and Petter Mowinckel, and Stefan Agewall, and Dan Atar, and Tore K Kvien
April 2017, Rheumatology international,
Sella A Provan, and Kristin Angel, and Anne Grete Semb, and Petter Mowinckel, and Stefan Agewall, and Dan Atar, and Tore K Kvien
November 2001, The Journal of rheumatology,
Copied contents to your clipboard!